Lipidio Pharmaceuticals
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $20M
Investors
- 2
About Lipidio Pharmaceuticals
Lipidio Pharmaceuticals Inc.Founded in 2020 and headquartered in San Diego, US, Lipidio Pharmaceuticals Inc. specializes in leveraging skin signaling mechanisms to create pharmaceutical products aimed at obesity management.Lipidio Pharma focuses on developing innovative pharmaceutical products that leverage the skin as an endocrine organ to address obesity. Their flagship product utilizes skin signaling mechanisms to promote systemic health benefits, including significant reductions in weight and total body fat, targeting diverse patient populations struggling with obesity.Lipidio Pharma generates revenue through partnerships with healthcare institutions and pharmaceutical distributors. Its business model includes direct sales to healthcare providers and agreements with wholesalers for market distribution.In November 2022, Lipidio Pharmaceuticals Inc. The company is focused on developing new products aimed at enhancing obesity management and plans for expansion into additional markets in Europe and Asia by 2024. These strategic initiatives are intended to broaden their reach and improve product deployment in response to the growing obesity epidemic.
Who invested in Lipidio Pharmaceuticals
2 investors across 1 round
See all investors in Lipidio Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 10, 2022
Amount
$20M
Investors
Questions about Lipidio Pharmaceuticals
Who invested in Lipidio Pharmaceuticals?
Lipidio Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lipidio Pharmaceuticals raised?
Lipidio Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Lipidio Pharmaceuticals last raise money?
Lipidio Pharmaceuticals's most recent round on record is a Series A, in Nov 2022.
What does Lipidio Pharmaceuticals do?
Lipidio Pharmaceuticals is a biotechnology company.
Where is Lipidio Pharmaceuticals headquartered?
Lipidio Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Lipidio Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lipidio Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Lipidio Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.